Latest News about NVO
Recent news which mentions NVO
From Benzinga
Why Novo Nordisk Stock Dropped Today
April 25, 2025
From Motley Fool
Top 2 Health Care Stocks That May Crash This Month
April 25, 2025
From Benzinga
Tickers
NVO
From Motley Fool
Trump Administration Considers Lowering US Drug Prices To International Levels: Report
April 23, 2025
From Benzinga
From Motley Fool
Is Eli Lilly Stock a Buy?
April 23, 2025
From Motley Fool
Eli Lilly Positioned To Dominate Obesity Market With Oral Option, Analyst Initiates With Confidence
April 22, 2025
From Benzinga
Think It's Too Late to Buy Novo Nordisk? Here's the Biggest Reason Why There's Still Time.
April 22, 2025
Tickers
NVO
From Motley Fool
Down 60%, Is This Growth Stock Too Cheap to Ignore?
April 22, 2025
From Motley Fool
Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip?
April 21, 2025
From Motley Fool
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
April 21, 2025
From Motley Fool
Eli Lilly's Experimental Weight Loss Pill Succeeded in Its First Pivotal Trial. Is It Time to Buy?
April 19, 2025
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
April 18, 2025
From Benzinga
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
April 18, 2025
From Benzinga
Where Will Eli Lilly Be in 5 Years?
April 18, 2025
From Motley Fool
Netflix, UnitedHealth, Novo Nordisk, Tesla And Trump Media: Why These 5 Stocks Are On Investors' Radars Today
April 17, 2025
From Benzinga
Eli Lilly Rallies Over 14%, Notches Best Day Since June 2000 On Oral Weight-Loss Drug Results: Analysts React
April 17, 2025
From Benzinga
Novo Nordisk May Lag Behind Eli Lilly In Cardiometabolic Race, Analyst Downgrades Stock
April 17, 2025
From Benzinga
From Benzinga
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide
April 17, 2025
From Motley Fool
From Benzinga
This Twin Disc Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
April 17, 2025
From Benzinga
From Benzinga
From Benzinga
Counterfeit Ozempic Identified in US Supply Chain With Fake Labels And Needles, FDA Alerts
April 15, 2025
From Benzinga
Skye Bioscience's Obesity Candidate Shows 30% Weight Loss When Combined With Eli Lilly's Blockbuster Drug In Animal Models
April 15, 2025
From Benzinga
Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch
April 15, 2025
From Benzinga
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.